About
Women's Healthcare
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
8
As Collaborator
0
Total Enrollment
4,186
By Phase
PHASE3: 3PHASE1/PHASE2: 1PHASE1: 3PHASE2: 1
By Status
COMPLETED: 8
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
Today
Hover over trial bars to see details
Recent Trials
NCT02158572Lead Sponsor
Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System
PHASE3Completed
2,032 participants
Started: Aug 31, 2014 · Completed: Nov 30, 2016
NCT01623466Lead Sponsor
Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only Patches
PHASE1/PHASE2Completed
36 participants
Started: Jul 31, 2012 · Completed: Sep 30, 2012
NCT01375946Lead Sponsor
Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions in Healthy Female Volunteers
PHASE1Completed
24 participants
Started: May 31, 2011 · Completed: Jun 30, 2011
NCT01422135Lead Sponsor
Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females
PHASE1Completed
24 participants
Started: Feb 28, 2011 · Completed: Apr 30, 2011
NCT01236768Lead Sponsor
Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm
PHASE3Completed
407 participants
Started: Oct 31, 2010 · Completed: Jun 30, 2011
Locations (1)
Headquarters
Princeton, NJ, United States
Map
Loading map...